Benjamin Dahl

Senior Associate

Benjamin Dahl

Senior Associate
“Patent disputes in the life sciences sit at the intersection of law, science, and business. I focus on understanding all three so that the strategy we develop serves not only the case at hand, but the client’s broader objectives.”
Benjamin Dahl represents companies in complex patent litigation and counselling matters, with a particular focus on Hatch-Waxman litigation involving Abbreviated New Drug Applications (ANDAs). Drawing on a scientific background in chemistry and biotechnology, he helps life sciences companies navigate patent disputes and intellectual property issues at the intersection of law, science, and commercial strategy.

A significant part of his practice involves pharmaceutical patent litigation. Ben has served on trial teams in high-stakes matters and represented clients in inter partes review proceedings before the U.S. Patent and Trademark Office. Beyond contentious matters, he counsels life sciences companies on patent portfolio analysis, due diligence, and freedom-to-operate issues, helping clients evaluate intellectual property risk and make informed decisions about their products and businesses.

His technical training gives Ben a strong foundation for understanding the science underlying pharmaceutical and biotechnology matters. He also recently completed MIT Professional Education program on artificial intelligence in the pharmaceutical industry, expanding his perspective on emerging technologies and their implications for drug development and the life sciences sector.

Before joining Michelman Robinson, Ben developed his practice at law firms with sophisticated intellectual property and life sciences capabilities, beginning his career at an intellectual property boutique focused on pharmaceutical patent litigation. He is also registered to practice before the U.S. Patent and Trademark Office.

Life Sciences

Mining

Real Estate

Associated Practice Areas

Commercial & Business Litigation

FDA Regulatory

Patent Litigation

 

Credentials

Bar & Court Admissions
  • New York
  • U.S. Patent and Trademark Office
Professional Affiliations
  • American Intellectual Property Law Association
Education
  • George Washington University School of Law, J.D.
  • Georgetown University, MS (Biotechnology)
  • Beloit College, BS (Environmental Chemistry)

Benjamin Dahl

Senior Associate
New York
+1 212-730-7700
https://www.mrllp.com/wp-content/uploads/2026/11/Dahl-Ben-NY-scaled.png
“Patent disputes in the life sciences sit at the intersection of law, science, and business. I focus on understanding all three so that the strategy we develop serves not only the case at hand, but the client’s broader objectives.”

Overview

Benjamin Dahl represents companies in complex patent litigation and counselling matters, with a particular focus on Hatch-Waxman litigation involving Abbreviated New Drug Applications (ANDAs). Drawing on a scientific background in chemistry and biotechnology, he helps life sciences companies navigate patent disputes and intellectual property issues at the intersection of law, science, and commercial strategy.

A significant part of his practice involves pharmaceutical patent litigation. Ben has served on trial teams in high-stakes matters and represented clients in inter partes review proceedings before the U.S. Patent and Trademark Office. Beyond contentious matters, he counsels life sciences companies on patent portfolio analysis, due diligence, and freedom-to-operate issues, helping clients evaluate intellectual property risk and make informed decisions about their products and businesses.

His technical training gives Ben a strong foundation for understanding the science underlying pharmaceutical and biotechnology matters. He also recently completed MIT Professional Education program on artificial intelligence in the pharmaceutical industry, expanding his perspective on emerging technologies and their implications for drug development and the life sciences sector.

Before joining Michelman Robinson, Ben developed his practice at law firms with sophisticated intellectual property and life sciences capabilities, beginning his career at an intellectual property boutique focused on pharmaceutical patent litigation. He is also registered to practice before the U.S. Patent and Trademark Office.

Life Sciences

Mining

Associated Practice Areas

Commercial & Business Litigation

Credentials

Bar & Court Admissions
  • New York
  • U.S. Patent and Trademark Office
Professional Affiliations
  • American Intellectual Property Law Association
Education
  • George Washington University School of Law, J.D.
  • Georgetown University, MS (Biotechnology)
  • Beloit College, BS (Environmental Chemistry)